Mark Burns
Family · Ruston, LANPI 1558034033
Payments from drug & device makers
Across 11 payments — averaging $15.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$54
- Ironshore Pharmaceuticals Inc.$40
- Exact Sciences$15
- Kowa Pharmaceuticals America, Inc.$14
- Merck$14
- Takeda Pharmaceuticals U.S.A., Inc.$12
- plus $20 from 2 others
What the payments were for
- Food & beverage$169100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 3 | $54 |
| Ironshore Pharmaceuticals Inc. | 2 | $40 |
| Exact Sciences | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Merck | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| Inogen, Inc. | 1 | $12 |
| Mayne Pharma Commercial LLC | 1 | $9 |
How this compares
$169 in reported general payments places this provider in the 25th percentile of 3,610 family providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PaxlovidNirmatrelvir/Ritonavir | 15 | $1,408 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $397 |
| Azelastine Hcl | 13 | $259 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 21 | $229 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 31 | $194 |
| Fluticasone Propionate | 23 | $145 |
| Ondansetron OdtOndansetron | 17 | $143 |
| Levothyroxine Sodium | 17 | $109 |
| Losartan Potassium | 24 | $89 |
| Lidocaine Hcl ViscousLidocaine Hcl | 11 | $82 |
| Fluconazole | 19 | $71 |
| Amoxicillin | 13 | $58 |
| Trazodone Hcl | 23 | $42 |
| Hydrochlorothiazide | 19 | $29 |
| Escitalopram Oxalate | 11 | $28 |
Paid to pharmacies, not to this prescriber.
Other family in Ruston
- Ashlea HillRuston$169K
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
- Rebekah GarrardLafayette$105K
- Tiffany RoeShreveport$97K
- Ghenet GhebretatiosBaton Rouge$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.